Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort Study.
En-Ling WuRebecca N KumarW Justin MooreGavin T HallIndre VysniauskaiteKwang-Youn A KimMichael P AngaroneValentina StosorMichael G IsonAdam Frink BbaChad J AchenbachKhalilah L GatesPublished in: Journal of general internal medicine (2022)
High-risk ambulatory patients with COVID-19 who identified as Hispanic/Latinx or Black were less likely to receive monoclonal antibody therapy in univariate analysis, a finding not explained by patient refusal. Multivariable and spatial analyses suggested insurance status, language, and social vulnerability contributed to racial disparities.